< Back to search
Filter
1

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

for
Primary Central Nervous System Lymphoma (PCNSL),
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07082868

Phase1, Recruiting

External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL

for
Diffuse Large B Cell Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07528352

Phase1, Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: New York NY, Indianapolis IN, Houston TX, Fort Worth TX,
Sponsor: Allterum Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07586618

Phase1, Recruiting

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

for
Follicular Helper T-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07293403

Phase2, Recruiting

HEME Home Transfusion Program

for
Leukemia, Myeloma, Myelodysplastic Syndromes,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06487247

Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer (NSCLC),
Location: Hackensack NJ, Fairfax VA, Atlanta GA, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07140016

Phase1, Recruiting

huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma

for
Relapsed or Refractory Follicular Lymphoma
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07343934

Phase1, Recruiting

Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study

for
Childhood Acute Lymphoblastic Leukemia,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 2 - 22

Code: NCT07071051

Recruiting

Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06675123

Phase1, Recruiting

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

for
Mantle Cell Lymphoma
Location: Toronto, Calgary, Vancouver
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT07341191

Phase2, Recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

for
Waldenström Macroglobulinemia, Lymphoplasmacytic Lymphoma,
Location: Boston MA
Sponsor: Shayna Sarosiek, MD

Sex: All

Age: 18+

Code: NCT06986174

Phase2, Recruiting

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07194980

Phase2, Recruiting

Q702 for the Treatment of Patients With Hematologic Malignancies

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06712810

Phase1, Recruiting

Pre-malignant States to Hematologic Malignancies in Firefighters

for
Clonal Hematopoiesis of Indeterminate Potential,
Location: Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 40 - 49

Code: NCT06870760

Recruiting

Epcoritamab and Rituximab for First-line Follicular Lymphoma

for
Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult
Location: Boston MA, New York NY, Rochester NY, Columbus OH,
Sponsor: Reid Merryman, MD

Sex: All

Age: 18+

Code: NCT05783609

Phase2, Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876649

Recruiting

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

for
Hodgkin Lymphoma
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 10 - 25

Code: NCT07222345

Recruiting

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

for
Relapsed and/or Refractory Mature T Cell Malignancy,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07055477

Phase1, Recruiting

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06905509

Phase2, Recruiting

Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)

for
Relapsed or Refractory Large B-cell Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06788964

Phase2, Recruiting